DibbsBarker launches ‘IP Ready’ tool with AusBiotech

The success of an innovative business often hinges on its intellectual property.

Recognising that IP rights are often misunderstood and their value can sometimes be overlooked, DibbsBarker has developed a new tool called ‘IP Ready’.

IP Ready is an online assessment designed to help users understand the main forms of IP that play an important role in innovative businesses, and identify gaps in their own IP knowledge. The tool is particularly relevant to those in the biotechnology, medical technology, health and life sciences sectors where new technologies are emerging constantly.

DibbsBarker partners Anna Feros and Rob McInnes led the creation of IP Ready, which was officially launched in Melbourne last week with the support of AusBiotech. AusBiotech is Australia’s biotechnology industry organisation that works on behalf of over 3,000 members to promote the global growth of Australian biotechnology. The organisation drew almost 400 attendees to its 2017 AusMedtech conference on 24-25 May, where IP Ready was unveiled by Mr McInnes.

“Many of our clients in R&D-based businesses have great ideas which are helping to save lives, enhance food security and make living more comfortable and efficient,” said Mr McInnes. “Our IP team has supported numerous organisations in getting Australian innovations off the ground through the protection and commercialisation of their IP. These services are more in demand than ever, particularly with the Australian Government’s focus on innovation to drive growth in our economy. With Melbourne being a hub for innovation in Australia, it was fitting for us to launch IP Ready there at last week’s AusMedtech conference. We’re delighted to have AusBiotech’s support.”

The team behind IP Ready set out to develop a tool that would be useful to a range of businesses, from budding start-ups through to established corporates.

“With IP Ready, we have created something that’s both free and easy to use, and relevant no matter how familiar a user might be with IP rights,” said Ms Feros. “For those who have never considered IP issues before, the tool is educational by helping users gain a basic understanding of the spectrum of IP rights. For those who are already familiar with IP rights and their management, the tool is a valuable ‘refresher’. It also helps users identify areas where IP risks might arise in ways that often get overlooked, such as how contract workers are engaged and how their creative output is captured and protected.”

Commenting on IP Ready, AusBiotech CEO Glenn Cross said: “At AusBiotech our mission is to foster a growing, strong and profitable biotechnology and life sciences industry in Australia. Our membership base ranges widely from early stage companies to mature multinationals and research organisations, but they are all alike in the way that IP plays a critical role in what they do and how successful they are. We’re delighted to endorse IP Ready and so pleased to see DibbsBarker’s investment in developing a resource that will benefit many.”

For more information about IP Ready, please contact:

Rob McInnes | Partner
+61 2 8233 9556 | M + 61 400 622 211

E rob.mcinnes@dibbsbarker.com

Anna Feros | Partner
+61 7 3100 5137 | M + 61 448 230 338

E anna.feros@dibbsbarker.com

 
Recent News
05 Sep 2017
DibbsBarker has appointed commercial litigation and insolvency expert Joanne Hardwick as the fourth partner in the firm’s Melbourne office.
29 Aug 2017
A team of 30 partners and staff from DibbsBarker’s Brisbane office took part in the annual Bridge to Brisbane charity run on 27 August, raising more than $10,000for QIMR Berghofer Medical Research Institute.
21 Aug 2017
DibbsBarker has acted for Windlab on its fully underwritten and oversubscribed initial public offering and listing on the ASX, raising $50 million. Windlab is an international renewable energy development company, focusing on identifying and efficiently developing, financing, constructing and operating high quality wind farms around the world.